Logo on white.png
EsoCap secures new funding
November 18, 2021 08:30 ET | EsoCap AG
EsoCap successfully closes a private financing round, with investments from existing and new investorsThe new funding was facilitated by EsoCap benefitting from a unique programme implemented by the...
Logo on white.png
EsoCap announces first patient enrolled in Phase II eosinophilic esophagitis trial
October 26, 2021 03:00 ET | EsoCap AG
Randomized, placebo-controlled, double-blind Phase II trial to treat 42 patients ongoing in four European countries with ESO-101ESO-101, EsoCap’s lead product candidate, consists of a capsule with a...
Diagram of EsoCap application, Krause et al. 2020. © EsoCap AG
EsoCap – unique targeted application platform to treat the upper gastrointestinal tract
September 09, 2021 03:00 ET | EsoCap AG
EsoCap’s targeted application technology drastically increases mucosal contact time and enables effective local treatment of various esophageal diseases for the first timeProof of principle in human...